CenterWatch

Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Illinois

UPDATED

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

UPDATED

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

UPDATED

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Ukraine

UPDATED

Dnepropetrovsk 49000

Prognostic Potential Cell Surface Marker and Pim-kinase in Patients With Hematologic Malignancies or Solid Tumors

Czech Republic

Prague

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Usti nad Labem

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

France

Bordeaux

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Lille

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Lyon

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Toulouse

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Germany

Aachen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Düsseldorf

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Tübingen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Italy

Milano

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Pisa

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Japan

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Sendai-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

View More ▼

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Netherlands

Amsterdam

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Nieuwegein

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Nijmegen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Russian Federation

Moscow

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Moscow

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

St. Petersburg

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Spain

A Coruna

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Alcalá de Henares

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Alcorcon

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Barcelona

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Barcelona

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

View More ▼

Barcelona

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Cádiz

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Madrid

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Oviedo

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

United Kingdom

Liverpool Merseyside L7 8XP

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoma or Lymphoproliferative Disorders